ARYA Sciences Acquisition Corp II
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $149.50M |
|---|---|
| IPO Date | Jun 5, 2020 |
| CEO | Adam Stone |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Cerevel Therapeutics |
| Deal Announced | Jul 30, 2020 |
| Deal Size, $M | $847.37M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Oct 26, 2020 |
| Amendment Vote | TBD |
| Closing Date | Oct 27, 2020 |
Formerly ARYB
CERE
CEREW
| Price | 45 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.